Today: 10 March 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Dow Jones Today (Dec. 22, 2025): DJIA Near 48,410 at 1:35 PM ET as AI-Led Rally Lifts Stocks Ahead of Key U.S. Data

Dow Jones Today (Dec. 22, 2025): DJIA Near 48,410 at 1:35 PM ET as AI-Led Rally Lifts Stocks Ahead of Key U.S. Data

The Dow Jones Industrial Average climbed 0.6% to around 48,414 in early afternoon trading Monday, lifted by gains in technology and AI-related stocks such as Nvidia and Micron. Chevron and Merck contributed significantly to the index’s rise, while Nike lagged. The S&P 500 and Nasdaq also advanced about 0.6%. Trading volumes remained light ahead of the holiday.
22 December 2025
···
UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group (UNH) Stock News, Forecasts and Analysis for Dec. 22, 2025: Independent Reviews, DOJ Scrutiny, and 2026 Guidance in Focus

UnitedHealth Group shares traded near $325.48 on Dec. 22, down slightly from the previous close. The company released initial findings from independent reviews of its Medicare Advantage, care management, and Optum Rx operations, citing broadly sound practices but highlighting areas for improved oversight. UnitedHealth plans to complete most recommended changes by the end of 2025.
22 December 2025
·
T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile US (TMUS) Stock News Today, Dec. 22, 2025: Bernstein Holds Neutral as SoftBank Stake Sales and 2026 Buyback Plan Shape the Outlook

T-Mobile shares traded near $195 midday Monday, down slightly, as SoftBank sold $4.8 billion of its stake to help fund a $22.5 billion OpenAI commitment, Reuters reported. The company recently authorized a $14.6 billion shareholder return program and will pay a $1.02 quarterly dividend in March. Bernstein reiterated a Neutral rating with a $265 target. Analyst consensus remains “Buy” with an average target of $262.
22 December 2025
·
Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery (WBD) Stock Today: Paramount Sweetens $30 Offer With Larry Ellison Guarantee as Netflix Secures New Financing

Warner Bros. Discovery shares rose Monday, closing near $28.70, after Paramount Skydance amended its $30-per-share hostile offer by adding a $40.4 billion personal guarantee from Larry Ellison. Netflix also revealed new financing moves for its agreed deal with WBD assets. Paramount extended its tender offer to January 21, 2026. Only 397,252 shares had been tendered as of December 19.
22 December 2025
··
Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon Stock (LULU) Today: Elliott’s $1B Stake, CEO Shake-Up, New 2026 Expansion—and What Wall Street Forecasts Next (Dec. 22, 2025)

Lululemon shares traded near $211 on Dec. 22, up 0.8%, as investors reacted to CEO Calvin McDonald’s planned departure and news of Elliott Management’s $1 billion-plus stake. Meghan Frank and André Maestrini will serve as interim co-CEOs starting Jan. 31. The company also announced expansion into six new international markets in 2026.
22 December 2025
··
Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks (PANW) Stock News Today: Google Cloud’s Near-$10 Billion Deal, AI-Security Momentum, and Analyst Forecasts (Dec. 22, 2025)

Palo Alto Networks shares rose 1.5% to $189.65 on Dec. 22 after news of an expanded Google Cloud partnership, reportedly worth nearly $10 billion over several years. The deal includes integrating Palo Alto’s AI security tools with Google Cloud services and expanding firewall and SASE deployments. Analysts highlighted the partnership’s potential to drive recurring revenue but noted execution risks remain.
22 December 2025
····
ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow (NOW) Stock News, Forecasts and Analyst Outlook for Dec. 22, 2025: Armis Deal Chatter, Stock Split Fallout, and What Investors Watch Next

ServiceNow shares traded at $156.25 as of 17:00 UTC, up 0.6% after a 5-for-1 stock split took effect Dec. 18. The company completed its acquisition of Moveworks and is in reported talks to buy cybersecurity firm Armis for up to $7 billion. Shares fell over 11% on Dec. 15 after the Armis news surfaced. Analyst concerns focus on deal size and growth strategy.
22 December 2025
·
Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs (GS) Stock Today, Dec. 22, 2025: Near Record High as M&A Tailwinds Meet Mixed 2026 Forecasts

Goldman Sachs shares traded near $903 by midday Monday, within 2% of their 52-week high, after a year of strong gains driven by robust dealmaking and client activity. Reuters data shows Goldman led investment banking fees in EMEA in 2025 with a 6.8% share. The bank’s next earnings report is due January 15, 2026. Analyst price targets remain below current stock levels.
22 December 2025
·
Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard (MA) Stock News Today: Fiserv Agentic Commerce Partnership, UAE Virtual Cards, Dividend & Buyback Boost, and Wall Street Forecasts (Dec. 22, 2025)

Mastercard shares rose 0.8% to $576.90 on Dec. 22 after Fiserv expanded its partnership with the company to scale AI-driven “agentic commerce” for merchants. Mastercard also announced a new B2B payments launch with First Abu Dhabi Bank and a 14% dividend increase with a $14 billion buyback. Fee-related litigation and regulation remain in focus.
22 December 2025
AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie Stock News Today (Dec. 22, 2025): ABBV Holds Near $227 as Drug-Pricing Talks, Dividend Growth, and 2026 Catalysts Come Into Focus

AbbVie shares traded at $227.73 midday Monday, near recent highs, as the company remains one of three major drugmakers not signed onto the White House’s new “most-favored-nation” drug-pricing agreements announced December 19. Investors are watching for AbbVie’s next move on the policy front, while its core immunology drugs and dividend growth continue to anchor fundamentals.
22 December 2025
···
Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen Stock (AMGN) News Today: Trump Drug‑Price Deals, Analyst Forecasts, and What to Watch Next — Dec. 22, 2025

Amgen shares rose to around $331 on December 22, 2025, after the White House announced drug-pricing deals with major drugmakers, including Amgen. The company will offer Aimovig and Amjevita at $299 per month through direct-to-patient sales. Analysts said the agreements may ease tariff and political risks but are unlikely to significantly affect pharma profits in the near term.
22 December 2025
··
Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot (HD) Stock Today: Latest News, Analyst Forecasts, and the 2026 Outlook Investors Are Pricing In (Dec. 22, 2025)

Home Depot shares traded around $347 Monday afternoon, up 0.7% for the day, as investors weighed new analyst commentary and 2026 outlooks. Wolfe Research nudged its price target to $415 and reiterated an Outperform rating. The stock remains down about 10% to 11% year-to-date, lagging the broader market. Trading volume and price range stayed steady, with no major corporate news.
22 December 2025
·
Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals (ALNY) Stock on Dec. 22, 2025: Nasdaq-100 Debut, AMVUTTRA Momentum, Analyst Price Targets and the 2026 Outlook

Alnylam Pharmaceuticals joined the Nasdaq-100 Index on Dec. 22, 2025, as the annual reconstitution took effect before the market opened. Shares traded near $405.60, up 1.3% from the prior close. The company recently announced a $250 million U.S. manufacturing expansion and reported strong adoption of its AMVUTTRA therapy for transthyretin amyloidosis.
22 December 2025
···
Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson Stock (JNJ) News Today: Latest Updates, Analyst Forecasts, and What Could Move Shares Next (Dec. 22, 2025)

Johnson & Johnson shares traded at $206.63 Monday after the European Commission approved TREMFYA for pediatric psoriasis, marking its first IL-23 inhibitor indication in children. The company also secured recent FDA approvals for RYBREVANT FASPRO in lung cancer and TRUFILL n-BCA for chronic subdural hematoma. Ongoing talc litigation continues to affect investor sentiment.
22 December 2025
·
Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems (MPWR) Stock on Dec. 22, 2025: Nasdaq-100 Debut, Analyst Targets, Dividend, and Fresh Technical Signals

Monolithic Power Systems joined the Nasdaq-100 Index before the market opened Monday, Dec. 22, 2025. Shares traded near $958.73, up 2.3% on the day, with a session range of $949.33 to $970.00. Analysts maintain a “Buy” consensus, with a 12-month average target of $1,196. The company declared a $1.56 quarterly dividend, payable Jan. 15, 2026.
22 December 2025
···
1 … 513 514 515 516 517 … 695
Go toTop